In the complex and fast-moving Precision Medicines market clients seek advisors who can provide deep scientific, technical and business insights at a local and global level. Part of the Healthcare and Life Sciences Strategy team, our Precision Medicine practice is a leader in this innovative area of medicine across all therapeutic areas, in markets around the world, with all relevant stakeholders and fueled by experience across the value chain.
Innovation and deal trends in Precision Medicine
Watch Kristin Pothier, KPMG Global and National Healthcare and Life Sciences Strategy Leader interview John Boyce, Managing Director and Co-Founder of TigerGene on the innovation, deals and capital flow within the Precision Medicines market
See us in action
Watch our Precision Medicine leaders talk about the practice and how KPMG is supporting our clients in their deals, and shaping their strategic direction and operations within this innovative industry